Comet Therapeutics
Company

Comet Therapeutics

Biotechnology Cambridge, Ma, United States 6 employees
Employees
6

Comet Therapeutics Overview

Headquarters
Cambridge, Ma, United States
Industry
Biotechnology
Employees
6
Founded
2018
Funding
28.5M

About Comet Therapeutics

CoEnzyme A (CoA) is essential to numerous cellular processes including the metabolism of fatty acids, amino acids and sugars, the regulation of gene expression, and the proper functioning of the TCA cycle and mitochondrial health, which generates the energy all cells need to live. There are many genetic, rare metabolic disorders that are CoA related. In addition, dysregulated CoA metabolism is a key factor in diseases as diverse as cancer, fatty liver and neurological disorders. While CoA has been in biochemistry textbooks for 70 years, there are no therapies to restore dysregulated coenzyme A metabolism. Comet Therapeutics addresses these profound unmet medical needs with its CoEnzyme Metabolism (CoMET™) Platform.

Compare Similar Companies to Comet Therapeutics